Published on: August 17, 2020 at 09:30PM
Conditions: Type 2 Diabetes Mellitus; Chronic Kidney Diseases
Interventions: Drug: Cotadutide 100 micrograms; Drug: Cotadutide 300 micrograms; Drug: Cotadutide 600 micrograms; Drug: Semaglutide; Drug: Placebo
Sponsor: AstraZeneca
Not yet recruiting
https://ift.tt/3iQSRia
Monday, 17 August 2020
New diabetes clinical trial: A Study of Cotadutide in Participants Who Have Chronic Kidney Disease With Type 2 Diabetes Mellitus
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Nothing happens without a Reason
Make Something out of it.